Vasculitis and Hearing loss

Summary:

Hearing loss is found among people with Vasculitis, especially for people who are female, 60+ old.

The study analyzes which people have Hearing loss with Vasculitis. It is created by eHealthMe based on reports of 29 people who have Vasculitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Vasculitis?

Vasculitis (inflammation of a blood vessel or blood vessels) is found to be associated with 970 drugs and 1,214 conditions by eHealthMe. Check the latest studies of Vasculitis.

What is Hearing loss?

Hearing loss is found to be associated with 1,358 drugs and 2,378 conditions by eHealthMe. Check the latest studies of Hearing loss.



On Jul, 10, 2026

29 people who have Vasculitis and Hearing Loss are studied.

Would you have Hearing loss when you have Vasculitis?

Gender of people who have Vasculitis and experienced Hearing Loss *:

  • female: 86.36 %
  • male: 13.64 %

Age of people who have Vasculitis and experienced Hearing Loss *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 6.67 %
  • 30-39: 13.33 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 80.0 %

Common co-existing conditions for these people *:

  1. Cogan's Syndrome (inflammation of the front of the eye (the cornea) and often fever, fatigue, and weight loss): 8 people, 27.59%
  2. Antineutrophil Cytoplasmic Antibody Positive: 8 people, 27.59%
  3. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 10.34%
  4. Blindness: 3 people, 10.34%
  5. Wegener's Granulomatosis (inflammation of the blood vessels lungs sinuses): 2 people, 6.90%
  6. Microscopic Polyangiitis (inflammation involving multiple blood or lymph small-vessel): 2 people, 6.90%
  7. Takayasu's Arteritis (an inflammation of the aorta -- the artery that carries blood from the heart to the rest of the body): 1 person, 3.45%
  8. Polyarteritis Nodosa (progressive disease of connective tissue): 1 person, 3.45%
  9. Labyrinthitis (inflammation of the labyrinth or inner ear): 1 person, 3.45%
  10. Hearing Impaired: 1 person, 3.45%

Common drugs taken by these people *:

  1. Rabeprazole: 8 people, 27.59%
  2. Vitamin B12: 7 people, 24.14%
  3. Tylenol: 6 people, 20.69%
  4. Methotrexate: 4 people, 13.79%
  5. Sulfamethoxazole And Trimethoprim: 4 people, 13.79%
  6. Cyclophosphamide: 3 people, 10.34%
  7. Humira: 3 people, 10.34%
  8. Prednisone: 3 people, 10.34%
  9. Calcium: 3 people, 10.34%
  10. Vitamin B3: 3 people, 10.34%

Common symptoms for these people *:

  1. Joint Pain: 13 people, 44.83%
  2. Fatigue (feeling of tiredness): 13 people, 44.83%
  3. Drug Ineffective: 13 people, 44.83%
  4. Pain In Extremity: 11 people, 37.93%
  5. Nausea (feeling of having an urge to vomit): 10 people, 34.48%
  6. Weakness: 9 people, 31.03%
  7. Hypotension (abnormally low blood pressure): 9 people, 31.03%
  8. Idiopathic Pulmonary Fibrosis (chronic lung disease): 9 people, 31.03%
  9. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 9 people, 31.03%
  10. Ear Discomfort: 8 people, 27.59%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hearing loss?

- Check whether Hearing loss is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hearing loss:

All the conditions that are associated with Hearing loss:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hearing loss and Vasculitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: